Mammites - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

Mammites

Description:

Cellules / ml de lait. ... Moyenne g om trique des analyses leucocytes du mois ... Analyse du bilan sanitaire et des documents de contr le laitier. – PowerPoint PPT presentation

Number of Views:107
Avg rating:3.0/5.0
Slides: 35
Provided by: Catheri211
Category:
Tags: analyse | lait | mammites

less

Transcript and Presenter's Notes

Title: Mammites


1
RUMINANTS Drying-off period management and
interest of CLOXAMAM
2
INTRODUCTION ON MASTITIS
  • Most common and most costly disease
  • of dairy cattle
  • In hers without effective mastitis control plan
    40 of the cows are infected
  • Estimated cost 200 k per cow per year
  • Reduced milk production accounts for about 70 of
    the total loss associated with mastitis

3
COW UDDER ANATOMY
4
UDDER DEFENCES - MECHANISM
5
UDDER DEFENCES
6
UDDER DEFENCES
  • Immune cells contained in the milk

7
THE BACTERIA WILL LEAD TO CELLS INFLUX
8
CONTROL OF THE MILK
9
MODERATE AGGRESSIVE BACTERIA LATE REPLY OF THE
ORGANISM
  • Sub clinical mastitis
  • Invisible mastitis nothing at first sight
  • Milk appearance modification (flakes, cloats)
  • No reduced milk yield
  • A kind of equilibrium takes place between
    bacteria and defenses cells

STAPHYLOCOCCUS AUREUS
10
WHAT OCCURS DURING A SUBLICLINICAL MASTITIS?
 Fight between leukocyte and bacteria 
11
THIS EXPLAINS CELLS COUNT VARIABILITY
Leukocyte 1000
Days
12
TWO KIND OF MASTITIS
  • Clinical mastitis Visible modifications
  • Milk appearance
  • And / or des other symptoms (temperature
    decreased milk yield udder aspect shock)
  • Subclinical mastitis No visible modification
  • Increased cells count
  • 10 decreased in milk yield
  • Bacteria stays in the udder. Consequence
    regular leukocyte efflux

13
TWO KIND OF MASTITIS
14
MASTITIS DIAGNOSIS
  • Clinical diagnosis use your eyes ? OK for
    clinical mastitis
  • Diagnosis in the farm ? Subclinical mastitis
  • CMT
  • Diagnosis in the lab ? For both
  • Somatic cell count
  • Bacteriological analysis

15
C.M.T. (CALIFORNIA MASTITIS TEST)
  • Rapid, accurate, simple to determine somatic cell
    count
  • CMT reagent reacts with the white blood cells and
    the mixture thickens or gels

16
C.M.T. (CALIFORNIA MASTITIS TEST)
  • In 10 sec. read the score while continuing to
    rotate the paddle
  • Reaction disappears in 20 sec.

17
MILK SAMPLE AND BACTERIOLOGICAL ANALYSIS
18
MAIN BACTERIA IMPLICATED IN MASTITIS
19
MODE OF TRANSMISSION OF BACTERIA
20
WHY TREATING MASTITIS?
  • Avoid contagiousness
  • Save money

21
FACTORS INFLUENCING MASTITIS INCIDENCE
22
MASTITIS CONTROL
23
MASTITIS CONTROL
24
OBJECTIVES OF DRY PERIOD TREATMENT
  • Improve udder health
  • Infections present at the time of drying off
    should be eliminated
  • The rate of new infections during dry period
    should be minimized

Beginning and end of dry period are at risk
25
OBJECTIVES OF DRY PERIOD TREATMENT
26
CLOXAMAM, THE COOPHAVET SOLUTION FOR DRYING OFF
27
CLOXAMAM CONTAINS CLOXACILLIN
  • Penicilline M
  • Gram spectrum including Staphylococcus and
    Streptococcus
  • Bactericidal antibiotic to limit the risk of
    chronic infection
  • It acts on the bacteria cell wall synthesis.
    Active on bacteria which are on the replication
    phase only.

28
CLOXAMAM ADVANTAGES
  • Cloxacillin is resistant to ?-lactamase secreted
    by gram bacteria (Staphylococcus)
  • Large diffusion in the udder parenchyma and
    exudates
  • Very low diffusion outside the udder (systemic
    for ex.)

29
CLOXAMAM ADVANTAGES
  • Antibiotic persistence in the udder
  • Cloxacillin is present under benzathine salt. It
    allows a long acting effect inside the udder.
  • The excipient is oily leading to a prolonged
    antibiotic activity
  • The excipient is long acting. It means it will
    keep the active ingredient at the infusion site
    and will let him diffuse slowly.
  • Most critical period for drying off management
    3 first weeks. This period is completely covered
    by CLOXAMAM.

30
CLOXAMAM PERSISTENCE
31
CLOXAMAM BENEFITS
  • Elimination of existing infections and prevention
    of new infections
  • Indications
  • Treatment of clinical mastitis due to
    Staphylococcus aureus, Streptococcus agalactiae,
    Streptococcus dysgalactiae, Streptococcus uberis
  • Prevention of new infection

32
ADVICES FOR CLOXAMAM ADMINISTRATION
  • Clean and dry teats
  • Disinfect each teat and with particular attention
    to the teat end (alcohol)
  • Insert only the tip of the cannula without
    touching anything else
  • Identify treated cows and removed them from the
    herd to prevent antibiotics in the tank

33
CONCLUSION
34
Thanks for your attention
Write a Comment
User Comments (0)
About PowerShow.com